Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

SynyiAI Completes $36 Million Funding for AI Healthcare Big Data

publication date: Jul 5, 2019

Shanghai Synyi Medical Technology completed a $36 million C funding round to support its AI-based big data healthcare operations. The company has developed technology that standardizes hospital medical records, including post-hospital follow-ups, and makes the information available through natural language queries. The company aims to provide data for medical research, healthcare and patient services. So far, SynyiAI is gathering information from 30 China hospitals. The C round was led by Tencent Holdings and included Sinopharm Capital. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital